Kailera Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $9.76-$28.23 |
Market Cap | $1.6B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.51 |
News
See moreYahoo Finance • 3 months ago
Kailera Therapeutics: The Record-Breaking Obesity IPO Big Pharma Cannot Ignore
Yahoo Finance • 4 months ago
Kailera Therapeutics (KLRA) is One of the Best IPO Stocks with Huge Upside Potential
Yahoo Finance • 4 months ago
Obesity drug developer Kalohexis files confidentially for U.S. IPO
Yahoo Finance • 4 months ago
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
About
CEO | Mr. Ronald C. Renaud Jr., M.B.A. |
Address | 180 Third Avenue, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 145 |